Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction
Key facts
- Who runs it
- Antalya Training and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 30 Mar 2026
- Expected to end
- 20 Dec 2026
- Type of study
- Observational
- Treatments tested
- Serial VEXUS Ultrasound Evaluation
- Record updated
- 22 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Age>18
- Patients monitored for septic shock in intensive care unit
- Signed informed consent
Who cannot take part
- Patients in whom venous structures cannot be clearly assessed via ultrasonography due to anatomical or technical reasons (e.g., adhesions following abdominal surgery)
- Patients receiving dialysis due to chronic kidney disease or initiating dialysis for acute kidney failure
- Chronic heart failure
- Patients with advanced valvular insufficiency or advanced pulmonary hypertension
- Patients with portal hypertension or advanced-stage liver cirrhosis
- Presence of acute or chronic thrombosis in the inferior vena cava or other venous structures within the scoring area
- Age <18
- Severe obesity precluding adequate ultrasonographic imaging
- Refusal to participate
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Septic shock or vexus
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the prognostic power of the VEXUS Score in predicting mortality among patients with septic shock in intensive care units.
The group in the trial
- Septic shock cohort
All patients diagnosed with septic shock in the ıntensive care unit will undergo serial ultrasonographic evaluations to calculate the VEXUS Score at 0-4 hours, 12-24 hours, and 72 hours. These scores will be analyzed in relation to 28-day mortality. No treatment decisions will be made based on the VEXUS results.
Treatment: Serial VEXUS Ultrasound Evaluation
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prognostic Power of the VEXUS Score in Septic Shock: Efficacy in Mortality Prediction
- Criteria questions
- Built from NCT07124741, who can take part
- Record updated
- 22 September 2026